IQVIA Holdings | مصروفات التشغيل

سعر السهم
165.62
التغيير اليومي
-3.74 -2.21%
شهريا
-31.39%
سنويا
-13.31%
Q1 التوقعات
160.49




مصروفات التشغيل تغيير تاريخ
Accenture USD 15.56B 629.65M 2025-09
Agilent USD 1.42B 57M 2025-09
Bruker USD 900.9M 124.3M 2025-12
Cardinal Health USD -2.88B 5M 2025-12
Celltrion KRW 724.99B 6B 2025-09
Charles River Laboratories USD 918.41M 2.49B 2025-12
Cigna USD 41.8B 23.4B 2025-09
Cognizant Technology Solutions USD 4.48B 10.42B 2025-12
Computer Programs Systems USD 87.92M 45.53M 2023-09
Cspc Pharmaceutical CNY 5.4B 298.41M 2025-09
CVS Health USD 103.58B 3.66B 2025-12
Danaher USD 5.34B 45.74B 2025-12
Dentsply International USD 1.48B 653M 2025-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 40.68M 5.56M 2025-09
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Elevance Health USD 49.17B 5.21B 2025-12
Hologic USD 349.4M 447.1M 2025-12
Humana USD 33.32B 1.07B 2025-12
IBM USD 15.44B 1.65B 2025-12
Illumina USD 903M 69M 2025-12
Infosys INR 370.7B 366.69B 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 89.06M 2.02M 2024-09
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Malin Corporation EUR 1.1M 400K 2024-12
McKesson USD 104.5B 2.85B 2025-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Organigram Holdings CAD 108.11M 17.03M 2025-09
Ovoca Bio EUR 5.65M 3.45M 2022-06
Pharma Mar EUR 39.62M 7.34M 2025-09
Publicis EUR 7.28B 247M 2025-06
Qiagen NV USD 418.54M 23.25M 2025-12
Quest Diagnostics USD 2.42B 4.84B 2025-12
Revvity USD 626.22M 25.62M 2025-12
Sartorius EUR 693.1M 29.4M 2025-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Tilray USD 237.52M 17.34M 2025-09
UnitedHealth USD 109.96B 1.11B 2025-12
Veeva Systems USD 570.38M 7.84M 2025-09
Veradigm USD 126.92M 29.33M 2022-09
Waters USD 661.85M 1.67B 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09


IQVIA Holdings مصروفات التشغيل - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.